Title : Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer.

Pub. Date : 2021 Jun 15

PMID : 34203709






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Multiple receptor tyrosine kinase (RTK) pathways contribute to the resistance of NSCLC to first- and third-generation EGFR-TKIs, such as erlotinib and osimertinib. osimertinib ret proto-oncogene Homo sapiens
2 Multiple receptor tyrosine kinase (RTK) pathways contribute to the resistance of NSCLC to first- and third-generation EGFR-TKIs, such as erlotinib and osimertinib. osimertinib ret proto-oncogene Homo sapiens